Virus Diseases [clinicaltrials_resource:a6f64ece6752177a842af57055655ecd]
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers [clinicaltrials:NCT00001164]clinicaltrials:NCT00110279Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination [clinicaltrials:NCT00219453]clinicaltrials:NCT00308412Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets [clinicaltrials:NCT00343278]clinicaltrials:NCT00347672clinicaltrials:NCT00366782clinicaltrials:NCT00380237Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [clinicaltrials:NCT00448604]Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults [clinicaltrials:NCT00488046]clinicaltrials:NCT00516035Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine [clinicaltrials:NCT00641017]Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine [clinicaltrials:NCT00722774]Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine [clinicaltrials:NCT00734175]clinicaltrials:NCT00749580A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B [clinicaltrials:NCT00815464]clinicaltrials:NCT00853255clinicaltrials:NCT00921726clinicaltrials:NCT00921934Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C [clinicaltrials:NCT00948220]Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older [clinicaltrials:NCT00975572]Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults [clinicaltrials:NCT00980447]Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults [clinicaltrials:NCT00984945]clinicaltrials:NCT01021397clinicaltrials:NCT01055990Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients [clinicaltrials:NCT01062659]Avian Influenza Studies In Lebanon [clinicaltrials:NCT01107262]Epidemiological Study in Children and Adolescents With Chronic Hepatitis B [clinicaltrials:NCT01163240]Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine [clinicaltrials:NCT01244867]clinicaltrials:NCT01289301Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005 AM4) [clinicaltrials:NCT01337167]A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006 AM2) [clinicaltrials:NCT01340937]Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) [clinicaltrials:NCT01341639]Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) [clinicaltrials:NCT01480258]Immunogenicity and Safety of V419 Given at 2, 3 and 4 Months of Age With Meningococcal Serogroup C Conjugate Vaccines [clinicaltrials:NCT01553279]DNA-based Influenza Vaccine in the Elderly [clinicaltrials:NCT01587131]Clinic-based ART Diagnostic Evaluation [clinicaltrials:NCT01791556]Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination [clinicaltrials:NCT01839175]Spanish Mixed HEXA/PENTA/HEXA Schedule [clinicaltrials:NCT01839188]Safety of H1N1 Influenza Vaccination in Pregnant Women [clinicaltrials:NCT01842997]
condition [clinicaltrials_vocabulary:condition]
The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU [clinicaltrials:NCT00000654]Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers [clinicaltrials:NCT00001164]Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection [clinicaltrials:NCT00001386]Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers [clinicaltrials:NCT00001560]Prevention of RSV Infections in Bone Marrow Transplant Recipients [clinicaltrials:NCT00001903]The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease [clinicaltrials:NCT00002001]An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia [clinicaltrials:NCT00002008]A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia [clinicaltrials:NCT00002009]The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment [clinicaltrials:NCT00002144]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection [clinicaltrials:NCT00004850]Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) [clinicaltrials:NCT00005274]Genetics of Hepatitis C Virus Infection [clinicaltrials:NCT00005657]Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus [clinicaltrials:NCT00005924]Collection of Liver Tissue for Virologic Studies [clinicaltrials:NCT00005936]Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer [clinicaltrials:NCT00006518]Study of Transfusion-Transmitted Infections [clinicaltrials:NCT00023023]Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [clinicaltrials:NCT00031473]Genetic Studies of Chronic Active Epstein-Barr Disease [clinicaltrials:NCT00032513]Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection [clinicaltrials:NCT00047814]Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia [clinicaltrials:NCT00054041]clinicaltrials:NCT00058591Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). [clinicaltrials:NCT00058604]clinicaltrials:NCT00058812Natural History of West Nile Virus Infection [clinicaltrials:NCT00069303]Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations [clinicaltrials:NCT00070785]clinicaltrials:NCT00110279Study to Evaluate MEDI-534 in Healthy Adults [clinicaltrials:NCT00111878]clinicaltrials:NCT00129766Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection [clinicaltrials:NCT00164060]Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection [clinicaltrials:NCT00164073]A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers [clinicaltrials:NCT00186927]Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults [clinicaltrials:NCT00192465]Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524 [clinicaltrials:NCT00192478]A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection [clinicaltrials:NCT00192504]Cultures a.m.Kamme-Lindbergh in Suspicion of Infected TKA [clinicaltrials:NCT00192686]clinicaltrials:NCT00194480Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant [clinicaltrials:NCT00209352]PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy [clinicaltrials:NCT00215865]Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination [clinicaltrials:NCT00219453]
condition browse [clinicaltrials_vocabulary:condition-browse]
The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU [clinicaltrials:NCT00000654]Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers [clinicaltrials:NCT00001164]Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection [clinicaltrials:NCT00001386]Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers [clinicaltrials:NCT00001560]Prevention of RSV Infections in Bone Marrow Transplant Recipients [clinicaltrials:NCT00001903]The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease [clinicaltrials:NCT00002001]An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia [clinicaltrials:NCT00002008]A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia [clinicaltrials:NCT00002009]The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment [clinicaltrials:NCT00002144]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection [clinicaltrials:NCT00004850]Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) [clinicaltrials:NCT00005274]Genetics of Hepatitis C Virus Infection [clinicaltrials:NCT00005657]Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus [clinicaltrials:NCT00005924]Collection of Liver Tissue for Virologic Studies [clinicaltrials:NCT00005936]Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer [clinicaltrials:NCT00006518]Study of Transfusion-Transmitted Infections [clinicaltrials:NCT00023023]Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients [clinicaltrials:NCT00031473]Genetic Studies of Chronic Active Epstein-Barr Disease [clinicaltrials:NCT00032513]Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection [clinicaltrials:NCT00047814]Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia [clinicaltrials:NCT00054041]clinicaltrials:NCT00058591Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). [clinicaltrials:NCT00058604]clinicaltrials:NCT00058812Natural History of West Nile Virus Infection [clinicaltrials:NCT00069303]Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations [clinicaltrials:NCT00070785]clinicaltrials:NCT00110279Study to Evaluate MEDI-534 in Healthy Adults [clinicaltrials:NCT00111878]clinicaltrials:NCT00129766Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection [clinicaltrials:NCT00164060]Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection [clinicaltrials:NCT00164073]A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers [clinicaltrials:NCT00186927]Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults [clinicaltrials:NCT00192465]Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524 [clinicaltrials:NCT00192478]A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Single Intravenous Dose of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), in Otherwise Healthy Children Hospitalized With RSV Infection [clinicaltrials:NCT00192504]Cultures a.m.Kamme-Lindbergh in Suspicion of Infected TKA [clinicaltrials:NCT00192686]clinicaltrials:NCT00194480Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant [clinicaltrials:NCT00209352]PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy [clinicaltrials:NCT00215865]Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination [clinicaltrials:NCT00219453]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Virus Diseases [clinicaltrials_resource:a6f64ece6752177a842af57055655ecd]
Bio2RDF identifier
a6f64ece6752177a842af57055655ecd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a6f64ece6752177a842af57055655ecd
identifier
clinicaltrials_resource:a6f64ece6752177a842af57055655ecd
title
Virus Diseases
@en
type
label
Virus Diseases [clinicaltrials_resource:a6f64ece6752177a842af57055655ecd]
@en
Virus Diseases